Inogen Price to Book Ratio 2012-2025 | INGN
Historical price to book ratio values for Inogen (INGN) over the last 10 years. The current price to book ratio for Inogen as of May 23, 2025 is 0.89.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Inogen Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2025-05-23 | 6.53 | 0.89 | |
2025-03-31 | 7.13 | $7.36 | 0.97 |
2024-12-31 | 9.17 | $7.27 | 1.26 |
2024-09-30 | 9.70 | $7.78 | 1.25 |
2024-06-30 | 8.13 | $7.91 | 1.03 |
2024-03-31 | 8.07 | $8.15 | 0.99 |
2023-12-31 | 5.49 | $8.78 | 0.63 |
2023-09-30 | 5.22 | $9.90 | 0.53 |
2023-06-30 | 11.55 | $11.85 | 0.97 |
2023-03-31 | 12.48 | $12.17 | 1.03 |
2022-12-31 | 19.71 | $12.96 | 1.52 |
2022-09-30 | 24.28 | $15.31 | 1.59 |
2022-06-30 | 24.18 | $15.59 | 1.55 |
2022-03-31 | 32.42 | $15.69 | 2.07 |
2021-12-31 | 34.00 | $16.29 | 2.09 |
2021-09-30 | 43.09 | $17.20 | 2.50 |
2021-06-30 | 65.17 | $16.43 | 3.97 |
2021-03-31 | 52.52 | $15.92 | 3.30 |
2020-12-31 | 44.68 | $15.80 | 2.83 |
2020-09-30 | 29.00 | $15.94 | 1.82 |
2020-06-30 | 35.52 | $15.91 | 2.23 |
2020-03-31 | 51.66 | $15.75 | 3.28 |
2019-12-31 | 68.33 | $15.64 | 4.37 |
2019-09-30 | 47.91 | $15.60 | 3.07 |
2019-06-30 | 66.76 | $15.22 | 4.39 |
2019-03-31 | 95.37 | $14.68 | 6.50 |
2018-12-31 | 124.17 | $14.25 | 8.71 |
2018-09-30 | 244.12 | $13.55 | 18.02 |
2018-06-30 | 186.33 | $12.52 | 14.89 |
2018-03-31 | 122.84 | $11.61 | 10.58 |
2017-12-31 | 119.08 | $10.82 | 11.00 |
2017-09-30 | 95.10 | $10.61 | 8.96 |
2017-06-30 | 95.42 | $10.03 | 9.51 |
2017-03-31 | 77.56 | $9.38 | 8.27 |
2016-12-31 | 67.17 | $8.93 | 7.52 |
2016-09-30 | 59.90 | $7.71 | 7.77 |
2016-06-30 | 50.11 | $7.35 | 6.82 |
2016-03-31 | 44.98 | $6.95 | 6.47 |
2015-12-31 | 40.09 | $6.77 | 5.92 |
2015-09-30 | 48.55 | $6.63 | 7.32 |
2015-06-30 | 44.60 | $6.61 | 6.75 |
2015-03-31 | 31.99 | $6.36 | 5.03 |
2014-12-31 | 31.37 | $6.20 | 5.06 |
2014-09-30 | 20.61 | $6.18 | 3.34 |
2014-06-30 | 22.56 | $6.08 | 3.71 |
2014-03-31 | 16.51 | $5.94 | 2.78 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $0.176B | $0.336B |
Inogen Inc. develops, manufactures and markets POC. POCs are used by patients who suffer from chronic respiratory conditions and need long-term oxygen therapy. POCs concentrate the air around the patient, filter out the nitrogen and other unwanted substances and deliver oxygen. The company provides oxygen concentrator solutions for portable and stationary use. Inogen's flagship product, One G4 is a single-solution POC. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Intuitive Surgical (ISRG) | United States | $193.381B | 84.70 |
Thermo Fisher Scientific (TMO) | United States | $148.604B | 17.98 |
Edwards Lifesciences (EW) | United States | $43.989B | 28.84 |
Alcon (ALC) | Switzerland | $42.675B | 28.84 |
IDEXX Laboratories (IDXX) | United States | $40.337B | 46.36 |
DexCom (DXCM) | United States | $33.137B | 51.22 |
STERIS (STE) | Ireland | $23.875B | 26.33 |
IQVIA Holdings (IQV) | United States | $23.701B | 13.28 |
Mettler-Toledo (MTD) | United States | $23.155B | 27.54 |
Waters (WAT) | United States | $20.612B | 29.08 |
SONOVA HOLDING (SONVY) | Switzerland | $19.146B | 0.00 |
Hologic (HOLX) | United States | $12.096B | 13.14 |
Sysmex ADR (SSMXY) | Japan | $10.632B | 30.16 |
Penumbra (PEN) | United States | $10.399B | 81.62 |
Masimo (MASI) | United States | $8.140B | 30.03 |
Globus Medical (GMED) | United States | $7.982B | 19.02 |
Glaukos (GKOS) | United States | $5.487B | 0.00 |
Teleflex (TFX) | United States | $5.337B | 8.81 |
TransMedics (TMDX) | United States | $4.203B | 91.36 |
Integer Holdings (ITGR) | United States | $4.128B | 21.63 |
PROCEPT BioRobotics (PRCT) | United States | $3.175B | 0.00 |
LivaNova (LIVN) | United Kingdom | $2.284B | 13.60 |
Veracyte (VCYT) | United States | $2.127B | 29.85 |
Nihon Kohden (NHNKY) | Japan | $1.943B | 22.28 |
Elekta AB (EKTAY) | Sweden | $1.922B | 17.28 |
Alphatec Holdings (ATEC) | United States | $1.820B | 0.00 |
Tandem Diabetes Care (TNDM) | United States | $1.380B | 0.00 |
Artivion (AORT) | United States | $1.222B | 114.44 |
Pulse Biosciences (PLSE) | United States | $1.136B | 0.00 |
OPKO Health (OPK) | United States | $0.999B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $0.956B | 5.08 |
SiBone (SIBN) | United States | $0.783B | 0.00 |
IRadimed (IRMD) | United States | $0.650B | 32.96 |
RxSight (RXST) | United States | $0.637B | 0.00 |
Beta Bionics (BBNX) | United States | $0.626B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.597B | 13.05 |
NeuroPace (NPCE) | United States | $0.580B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.569B | 8.86 |
Delcath Systems (DCTH) | United States | $0.561B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.506B | 0.00 |
AxoGen (AXGN) | United States | $0.504B | 0.00 |
Semler Scientific (SMLR) | United States | $0.494B | 13.15 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.433B | 0.00 |
AngioDynamics (ANGO) | United States | $0.384B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.370B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.333B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.277B | 0.00 |
Neuronetics (STIM) | United States | $0.263B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.219B | 13.27 |
Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.175B | 0.00 |
CVRx (CVRX) | United States | $0.174B | 0.00 |
908 Devices (MASS) | United States | $0.172B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.172B | 0.00 |
Sight Sciences (SGHT) | United States | $0.165B | 0.00 |
Accuray (ARAY) | United States | $0.162B | 0.00 |
LENSAR (LNSR) | United States | $0.160B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.144B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.143B | 0.00 |
Anteris Technologies Global (AVR) | Australia | $0.131B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.123B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.093B | 0.00 |
InspireMD (NSPR) | Israel | $0.078B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.077B | 46.90 |
EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.059B | 0.00 |
Covalon Technologies (CVALF) | Canada | $0.055B | 16.67 |
Hyperfine (HYPR) | United States | $0.042B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.040B | 0.00 |
Spectral AI (MDAI) | United States | $0.037B | 0.00 |
Envoy Medical (COCH) | United States | $0.035B | 0.00 |
Precision Optics (POCI) | United States | $0.033B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.032B | 0.00 | |
DarioHealth (DRIO) | United States | $0.032B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
NexGel (NXGL) | United States | $0.017B | 0.00 |
PAVmed (PAVM) | United States | $0.011B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
Tenon Medical (TNON) | United States | $0.008B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
Nuwellis (NUWE) | United States | $0.004B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
Venus Concept (VERO) | Canada | $0.003B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
Avinger (AVGR) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.58 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |